Centrient Pharmaceuticals
Nitin Guglani serves as the Head Of Accounting and Treasury at Centrient Pharmaceuticals since September 2019. Previously, Nitin held the position of General Manager Finance and Head of Accounting at Michelin from June 2014 to September 2019. Nitin's career also includes significant roles at GSK Consumer Healthcare India, where responsibilities included Finance Manager for Corporate Accounting and Deputy Manager for Business Partnering, Closing, and Reporting from May 2010 to June 2014. Early professional experience includes positions at Future Axiom Telecom Ltd as Assistant Manager Finance, Genpact as Assistant Manager Finance and Management Trainee, and educational credentials include a Chartered Accountant degree obtained from The Institute of Chartered Accountants of India between 2002 and 2006.
This person is not in any teams
This person is not in any offices
Centrient Pharmaceuticals
2 followers
Centrient Pharmaceuticals is the global business-to-business leader in sustainable, enzymatic antibiotics, next generation statins and anti-fungals. We produce and sell intermediates and active pharmaceutical ingredients (APIs), as well as our own tablets, capsules and other finished dosage forms (FDFs). We stand proudly at the centre of modern healthcare, as a maker of essential and life-saving medicines. With our commitment to Quality, Reliability and Sustainability at the heart of everything we do, our over 1,800 employees work continuously to meet our customers’ needs. We work towards a sustainable future by actively participating in the fight against antimicrobial resistance. Founded 150 years ago as the ‘Nederlandsche Gist- en Spiritusfabriek’, our company was known as Gist Brocades and more recently DSM Sinochem Pharmaceuticals. Headquartered in Rotterdam (Netherlands), we have production facilities and sales offices in China, India, the Netherlands, Spain, the United States and Mexico. Centrient Pharmaceuticals is owned by Bain Capital Private Equity, a leading global private investment firm.